Indeed, data have shown that patients with elevated thyroglobulin antibodies (TgAbs) and/or thyroid peroxidase antibodies (TPOAbs) at baseline were more likely to develop overt thyroid disease or more severe hypothyroidism following ICI treatment. This evidence concerns the gene TG and thyroid gland disorder.